TY - JOUR AU - Wang, J. C. PY - 1985 DA - 1985// TI - DNA topoisomerases JO - Annu Rev Biochem VL - 54 UR - https://doi.org/10.1146/annurev.bi.54.070185.003313 DO - 10.1146/annurev.bi.54.070185.003313 ID - Wang1985 ER - TY - JOUR AU - Gottlieb, J. A. AU - Guarino, A. M. AU - Call, J. B. AU - Oliverio, V. T. AU - Block, J. B. PY - 1970 DA - 1970// TI - Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880) JO - Cancer Chemother Rep VL - 54 ID - Gottlieb1970 ER - TY - JOUR AU - Hertzberg, R. P. AU - Caranfa, M. J. AU - Holden, K. G. AU - Jakas, D. R. AU - Gallagher, G. AU - Mattern, M. R. AU - Mong, S. M. AU - Bartus, J. O. AU - Johnson, R. K. AU - Kingsbury, W. D. PY - 1989 DA - 1989// TI - Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity JO - J Med Chem VL - 32 UR - https://doi.org/10.1021/jm00123a038 DO - 10.1021/jm00123a038 ID - Hertzberg1989 ER - TY - JOUR AU - Hsiang, Y. H. AU - Hertzberg, R. AU - Hecht, S. AU - Liu, L. F. PY - 1985 DA - 1985// TI - Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I JO - J Biol Chem VL - 260 ID - Hsiang1985 ER - TY - JOUR AU - Giovanella, B. C. AU - Stehlin, J. S. AU - Wall, M. E. AU - Wani, M. C. AU - Nicholas, A. W. AU - Liu, L. F. AU - Silber, R. AU - Potmesil, M. PY - 1989 DA - 1989// TI - DNA topoisomerase I – targeted chemotherapy of human colon cancer in xenografts JO - Science VL - 246 UR - https://doi.org/10.1126/science.2555920 DO - 10.1126/science.2555920 ID - Giovanella1989 ER - TY - JOUR AU - Del Bino, G. AU - Lassota, P. AU - Darzynkiewicz, Z. PY - 1991 DA - 1991// TI - The S-phase cytotoxicity of camptothecin JO - Exp Cell Res VL - 193 UR - https://doi.org/10.1016/0014-4827(91)90534-2 DO - 10.1016/0014-4827(91)90534-2 ID - Del Bino1991 ER - TY - JOUR AU - Gerrits, C. J. AU - Burris, H. AU - Schellens, J. H. AU - Eckardt, J. R. AU - Planting, A. S. AU - van der Burg, M. E. AU - Rodriguez, G. I. AU - Loos, W. J. AU - van Beurden, V. AU - Hudson, I. AU - Fields, S. AU - Von Hoff, D. D. AU - Verweij, J. PY - 1998 DA - 1998// TI - Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors JO - Clin Cancer Res VL - 4 ID - Gerrits1998 ER - TY - JOUR AU - Houghton, P. J. AU - Cheshire, P. J. AU - Hallman, J. D. AU - Lutz, L. AU - Friedman, H. S. AU - Danks, M. K. AU - Houghton, J. A. PY - 1995 DA - 1995// TI - Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors JO - Cancer Chemother Pharmacol VL - 36 UR - https://doi.org/10.1007/BF00686188 DO - 10.1007/BF00686188 ID - Houghton1995 ER - TY - JOUR AU - Gupta, E. AU - Vyas, V. AU - Ahmed, F. AU - Sinko, P. AU - Cook, T. AU - Rubin, E. PY - 2000 DA - 2000// TI - Pharmacokinetics of orally administered camptothecins JO - Ann NY Acad Sci VL - 922 UR - https://doi.org/10.1111/j.1749-6632.2000.tb07038.x DO - 10.1111/j.1749-6632.2000.tb07038.x ID - Gupta2000 ER - TY - JOUR AU - Drengler, R. L. AU - Kuhn, J. G. AU - Schaaf, L. J. AU - Rodriguez, G. I. AU - Villalona-Calero, M. A. AU - Hammond, L. A. AU - Stephenson, J. A. AU - Hodges, S. AU - Kraynak, M. A. AU - Staton, B. A. AU - Elfring, G. L. AU - Locker, P. K. AU - Miller, L. L. AU - Von Hoff, D. D. AU - Rothenberg, M. L. PY - 1999 DA - 1999// TI - Phase I and pharmacokinetic trial of oral irinotecan administered daily for 5 days every 3 weeks in patients with solid tumors JO - J Clin Oncol VL - 17 ID - Drengler1999 ER - TY - JOUR AU - Schellens, J. H. AU - Creemers, G. J. AU - Beijnen, J. H. AU - Rosing, H. AU - Boer-Dennert, M. AU - McDonald, M. AU - Davies, B. AU - Verweij, J. PY - 1996 DA - 1996// TI - Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor JO - Br J Cancer VL - 73 UR - https://doi.org/10.1038/bjc.1996.243 DO - 10.1038/bjc.1996.243 ID - Schellens1996 ER - TY - JOUR AU - Verschraegen, C. F. AU - Natelson, E. A. AU - Giovanella, B. C. AU - Kavanagh, J. J. AU - Kudelka, A. P. AU - Freedman, R. S. AU - Edwards, C. L. AU - Ende, K. AU - Stehlin, J. S. PY - 1998 DA - 1998// TI - A phase I clinical and pharmacological study of oral 9-nitrocamptothecin, a novel water-insoluble topoisomerase I inhibitor JO - Anticancer Drugs VL - 9 UR - https://doi.org/10.1097/00001813-199801000-00004 DO - 10.1097/00001813-199801000-00004 ID - Verschraegen1998 ER - TY - JOUR AU - Scott, D. O. AU - Bindra, D. S. AU - Sutton, S. C. AU - Stella, V. J. PY - 1994 DA - 1994// TI - Urinary and biliary disposition of the lactone and carboxylate forms of 20(S)-camptothecin in rats JO - Drug Metab Dispos VL - 22 ID - Scott1994 ER - TY - JOUR AU - Ma, J. AU - Maliepaard, M. AU - Nooter, K. AU - Loos, W. J. AU - Kolker, H. J. AU - Verweij, J. AU - Stoter, G. AU - Schellens, J. H. PY - 1998 DA - 1998// TI - Reduced cellular accumulation of topotecan: a novel mechanism of resistance in a human ovarian cancer cell line JO - Br J Cancer VL - 77 UR - https://doi.org/10.1038/bjc.1998.270 DO - 10.1038/bjc.1998.270 ID - Ma1998 ER - TY - JOUR AU - Yang, C. J. AU - Horton, J. K. AU - Cowan, K. H. AU - Schneider, E. PY - 1995 DA - 1995// TI - Cross-resistance to camptothecin analogues in a mitoxantrone-resistant human breast carcinoma cell line is not due to DNA topoisomerase I alterations JO - Cancer Res VL - 55 ID - Yang1995 ER - TY - JOUR AU - Rajendra, R. AU - Gounder, M. K. AU - Saleem, A. AU - Schellens, J. H. AU - Ross, D. D. AU - Bates, S. E. AU - Sinko, P. J. AU - Rubin, E. H. PY - 2003 DA - 2003// TI - Differential effects of the breast cancer resistance protein on the cellular accumulation and cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecin JO - Cancer Res VL - 63 ID - Rajendra2003 ER - TY - JOUR AU - Williams, G. C. AU - Liu, A. AU - Knipp, G. AU - Sinko, P. J. PY - 2002 DA - 2002// TI - Direct evidence that saquinavir is transported by multidrug resistance-associated protein (MRP1) and canalicular multispecific organic anion transporter (MRP2) JO - Antimicrob Agents Chemother VL - 46 UR - https://doi.org/10.1128/AAC.46.11.3456-3462.2002 DO - 10.1128/AAC.46.11.3456-3462.2002 ID - Williams2002 ER - TY - JOUR AU - Liang, E. AU - Proudfoot, J. AU - Yazdanian, M. PY - 2000 DA - 2000// TI - Mechanisms of transport and structure–permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers JO - Pharm Res VL - 17 UR - https://doi.org/10.1023/A:1026450326712 DO - 10.1023/A:1026450326712 ID - Liang2000 ER - TY - JOUR AU - Gupta, E. AU - Luo, F. AU - Lallo, A. AU - Ramanathan, S. AU - Vyas, V. AU - Rubin, E. AU - Sinko, P. PY - 2000 DA - 2000// TI - The intestinal absorption of camptothecin, a highly lipophilic drug, across Caco-2 cells is mediated by active transporter(s) JO - Anticancer Res VL - 20 ID - Gupta2000 ER - TY - JOUR AU - Hidalgo, I. J. AU - Borchardt, R. T. PY - 1990 DA - 1990// TI - Transport of a large neutral amino acid (phenylalanine) in a human intestinal epithelial cell line: Caco-2 JO - Biochim Biophys Acta VL - 1028 UR - https://doi.org/10.1016/0005-2736(90)90261-L DO - 10.1016/0005-2736(90)90261-L ID - Hidalgo1990 ER - TY - JOUR AU - Hyafil, F. AU - Vergely, C. AU - Du, P. V. i. g. n. a. u. d. AU - Grand-Perret, T. PY - 1993 DA - 1993// TI - In vitro and in vivo reversal of multidrug resistance by GF120918 an acridonecarboxamide derivative JO - Cancer Res VL - 53 ID - Hyafil1993 ER - TY - JOUR AU - Makhey, V. D. AU - Guo, A. AU - Norris, D. A. AU - Hu, P. AU - Yan, J. AU - Sinko, P. J. PY - 1998 DA - 1998// TI - Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells JO - Pharm Res VL - 15 UR - https://doi.org/10.1023/A:1011971303880 DO - 10.1023/A:1011971303880 ID - Makhey1998 ER - TY - JOUR AU - Chu, X. Y. AU - Kato, Y. AU - Sugiyama, Y. PY - 1999 DA - 1999// TI - Possible involvement of P-glycoprotein in biliary excretion of CPT-11 in rats JO - Drug Metab Dispos VL - 27 ID - Chu1999 ER - TY - JOUR AU - Sugiyama, Y. AU - Kato, Y. AU - Chu, X. PY - 1998 DA - 1998// TI - Multiplicity of biliary excretion mechanisms for the camptothecin derivative irinotecan (CPT-11), its metabolite SN-38, and its glucuronide: role of canalicular multispecific organic anion transporter and P-glycoprotein JO - Cancer Chemother Pharmacol VL - 42 UR - https://doi.org/10.1007/s002800051078 DO - 10.1007/s002800051078 ID - Sugiyama1998 ER - TY - JOUR AU - Bellamy, W. T. PY - 1996 DA - 1996// TI - P-glycoproteins and multidrug resistance JO - Annu Rev Pharmacol Toxicol VL - 36 UR - https://doi.org/10.1146/annurev.pa.36.040196.001113 DO - 10.1146/annurev.pa.36.040196.001113 ID - Bellamy1996 ER - TY - JOUR AU - Hendricks, C. B. AU - Rowinsky, E. K. AU - Grochow, L. B. AU - Donehower, R. C. AU - Kaufmann, S. H. PY - 1992 DA - 1992// TI - Effect of P-glycoprotein expression on the accumulation and cytotoxicity of topotecan (SK&F 104864), a new camptothecin analogue JO - Cancer Res VL - 52 ID - Hendricks1992 ER - TY - JOUR AU - Jansen, W. J. AU - Hulscher, T. M. AU - Ark-Otte, J. AU - Giaccone, G. AU - Pinedo, H. M. AU - Boven, E. PY - 1998 DA - 1998// TI - CPT-11 sensitivity in relation to the expression of P170-glycoprotein and multidrug resistance-associated protein JO - Br J Cancer VL - 77 UR - https://doi.org/10.1038/bjc.1998.58 DO - 10.1038/bjc.1998.58 ID - Jansen1998 ER - TY - JOUR AU - Vanhoefer, U. AU - Muller, M. R. AU - Hilger, R. A. AU - Lindtner, B. AU - Klaassen, U. AU - Schleucher, N. AU - Rustum, Y. M. AU - Seeber, S. AU - Harstrick, A. PY - 1999 DA - 1999// TI - Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell lines JO - Br J Cancer VL - 81 UR - https://doi.org/10.1038/sj.bjc.6694384 DO - 10.1038/sj.bjc.6694384 ID - Vanhoefer1999 ER - TY - JOUR AU - Chen, A. Y. AU - Yu, C. AU - Potmesil, M. AU - Wall, M. E. AU - Wani, M. C. AU - Liu, L. F. PY - 1991 DA - 1991// TI - Camptothecin overcomes MDR1-mediated resistance in human KB carcinoma cells JO - Cancer Res VL - 51 ID - Chen1991 ER - TY - JOUR AU - Hoki, Y. AU - Fujimori, A. AU - Pommier, Y. PY - 1997 DA - 1997// TI - Differential cytotoxicity of clinically important camptothecin derivatives in P-glycoprotein-overexpressing cell lines JO - Cancer Chemother Pharmacol VL - 40 UR - https://doi.org/10.1007/s002800050682 DO - 10.1007/s002800050682 ID - Hoki1997 ER - TY - JOUR AU - Mattern, M. R. AU - Hofmann, G. A. AU - Polsky, R. M. AU - Funk, L. R. AU - McCabe, F. L. AU - Johnson, R. K. PY - 1993 DA - 1993// TI - In vitro and in vivo effects of clinically important camptothecin analogues on multidrug-resistant cells JO - Oncol Res VL - 5 ID - Mattern1993 ER - TY - JOUR AU - Mouly, S. AU - Paine, M. F. PY - 2003 DA - 2003// TI - P-glycoprotein increases from proximal to distal regions of human small intestine JO - Pharm Res VL - 20 UR - https://doi.org/10.1023/A:1026183200740 DO - 10.1023/A:1026183200740 ID - Mouly2003 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1741-7015/2/16/prepub UR - http://www.biomedcentral.com/1741-7015/2/16/prepub ID - ref33 ER -